Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
Cancer with all its more than 200 variants continues to be a major health problem around the world with nearly 10 million deaths recorded in 2020, and leukemia accounted for more than 300,000 cases according to the Global Cancer Observatory. Although new treatment strategies are currently being deve...
Main Authors: | Paul A. Valle, Raul Garrido, Yolocuauhtli Salazar, Luis N. Coria, Corina Plata |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/7/1396 |
Similar Items
-
CAR-T Cell Therapy for the Treatment of ALL: Eradication Conditions and In Silico Experimentation
by: Paul A. Valle, et al.
Published: (2021-07-01) -
Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
by: Seiter K, et al.
Published: (2015-06-01) -
Efficacy of combination of rituximab therapy with chlorambucil plus prednisolone (R-LP) Protocol as treatment line in chronic lymphocytic leukemia patients
by: Waseem F Al Tameemi
Published: (2015-01-01) -
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01) -
Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis
by: Monia Marchetti, et al.
Published: (2022-03-01)